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Summary:-
The relationship between surgery and
diabetes mellitus is examined, principally in
terms of the diabetic patient who is subjected
to operation. However, account is also
taken of situations where diabetes may be
precipitated or, indeed, treated by surgical
intervention.
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Surgery and Diabetes Mellitus
Although diabetes mellitus is regarded primarily as a
medical condition, it has wide-ranging implications for
the surgeon especially in terms of the diabetic patient
undergoing a surgical procedure.
In addition, it is becoming increasingly evident that
surgery may have an important role in the treatment of
the disease and its complications, and to facilitate
discussion of this extensive subject the essay will be
divided into 3 sections:-
1. Complications and Management of Diabetes
Mellitus in the Surgical Patient.
2. Surgery and Surgical Conditions Precipitating
Diabetes Mellitus and related metabolic
disorders.
3. Treatment of Diabetes Mellitus and its
complications by Surgery.
1. Complications and Management of Diabetes Mellitus
in the Surgical Patient.
Regardless of the reason for operation, the diabetic
patient presents a special challenge not only because
of the impairment of glucose and lipid metabolism and
the consequent effect on electrolyte and fluid balance,
but also because of dysfunction in the vascular tree,
the immunological system and the wound healing process.
It is therefore essential that diabetes is not "palmed
off" on to the medical side but is treated as an
integral part of the surgical condition so that an
optimal state for operation is achieved.
i) Surgery as a potential diabetogenic stimulus.
Any patient undergoing surgery faces 3 stress
situations - anxiety, anaesthesia,and surgical
trauma; in the diabetic patient this
combination may lead to metabolic decompensation.
Anxiety stress causes sympathetic stimulation and
release of corticosteroids and adrenaline
adding to the similar effect of surgical stress
on these factors.
Anaesthesia certainly raises blood sugar,
especially when chloroform or ether is used, but
the observed rise is only 10 - 50 mg/100 mis
(Steinke 71), and the choice of general
anaesthetic is not influenced by the presence of
diabetes mellitus (Galloway 67, Shipp 68).
However, anaesthetic management should be designed
to cause minimal stress and to be rapidly reversible
so that the patient may be fed orally as soon as
possible. A general anaesthetic should therefore
be as "light" as possible to allow a rapid return
to consciousness with little nausea and vomiting.
Local anaesthetic is the method of choice when
feasible and elderly patients may even undergo
amputation with spinal anaesthesia (Marble 63);
the consequent sensory denervation may even have
positive value in atherosclerosis as it causes
peripheral vasodilation, but a careful watch must
be kept for the arterial hypotension which follows
sympathetic denervation (Greene 67). Pre-operative
medication should be kept to a minimum as diabetic
patients, especially the elderly, are often sensitive
to narcotics and sedatives and the inherent danger
of respiratory-depressed hypercarbia, hypoxia and
acidosis is exaggerated (Marble 63). Morphine also
causes/
causes release of ACTH (Johnston 73) and should thus
he avoided as glucocorticoids are markedly
diabetogenic.
Surgical trauma is the greatest compromising factor
in this trio and the degree of stress, as measured by
elevated blood sugar, depends on the duration and
magnitude of the procedure; intraabdominal
manipulation seems to be the most stressful
situation (Clarke 70). What is "stress" and how
does it elevate blood sugar and precipitate diabetic
coma in the susceptible patient? The answer to this
question, as far as we can answer it, is a multifactorial
one. As already suggested, nervous and endocrine
mechanisims play a central role in the stress reaction.
The common factor is probably any painful stimulus,
especially that arising from traction on the viscera,
which transmits impulses centrally to the spinal cord
and midbrain causing reflex secretion of the appropriate
hormones, even under profound anaesthesia. It is
significant that ACTH and Cortisol levels do not rise
in injury to paraplegic limbs and are delayed and reduced
in spinal anaesthesia (Johnston 73). The hormones
concerned have a complex, interacting effect on
metabolism and it is best to consider them in turn.
Adrenaline rises markedly during major surgery due to
sympathetic stimulation of the adrenal medulla and remains
high well into the recovery phase. This stimulates
glycogenolysis, decreases glucose uptake in muscle,
inhibits pancreatic insulin release and stimulates
glucagon release and mobilises free fatty acids due
to activation of triglyceride lipase.
Cortisol levels rise during surgery as a result of ACTH
release. Owing to this gluconeogenesis is increased,
glucose uptake in adipose tissue is decreased and free
fatty acids are mobilised by the activated lipase. It
is now considered that the metabolic implications of
adrenocortical secretions in the post-operative period
are small (Johnson 73) but in the diabetic patient
glucocorticoids may be a major factor in decompensation.
Glucagon also crises in response to surgery, due to a
combination of nervous sympathetic stimulation of the
pancreas and the releasing effect of circulating
adrenaline. This stimulates liver gluconeogenesis and
glycoggnolysband again mobilises free fatty acids by an
action on the triglyceride lipase.
Growth Hormone/
Growth Hormone levels tend to rise in the post-operative
stage; this stimulates gluconeogenesis, decreases
glucose uptake by adipose tissue and mobilises free
fatty acids. The hormone is also thought to release
somatomedin from the liver which antagonises insulin
by binding to receptors on the fat cell membrane.
Insulin secretion during surgery is reduced but in the
first few days after the operation there is a paradoxical
increase and high levels of insulin are found at a time
when glucose metabolism is still impaired. At this
time many insulin antagonists are present - adrenaline,
Cortisol, glucugon, GH and sympathetic stimulation of
the pancreas itself. The insulin rise is probably
due to hyperglycaemia and to the effect of glucagon;
this may explain poor glucose uptake in the face of
high insulin levels (See pseudo-diabetes). In addition
a traumatic cell membrane defect may result in a certain
degree of of insulin resistance (Johnston 73). Insulin,
of course, is the hypoglycaemic hormone, increasing
glucose uptake in all tissues save brain and red blood
cells, inhibiting glycogenolysis, gluconeogenesis
and lipolysis, and stimulating glycogen synthesis.
Thus the actions of these hormones under the stimulus
of trauma is to precipitate hyperglycaemia and, to
a lesser extent, ketosis (See diagrams 1 and 2).
If this happens in the normal patient, then the diabetic
will be in dire straits, as his metabolic tendencies are
already in this direction due to a relative or absolute
insulin deficiency. It is therefore mandatory that
the patient's metabolic condition be kept as stable as
possible around the time of surgery.
Electrolyte and Fluid Imbalances of the Diabetic State and
their dangers.
Having examined the mechanism of metabolic decompensation
in response to surgical trauma it is now appropriate to
look at the effects of this process and the ways in' which
they endanger the patient. The changes are similar to
those seen in uncontrolled diabetes, where the precipitating
factor is insulin lack, but during and after surgery they
are more likely to occur, as has been discussed above.
Diabetic coma, as the state of metabolic decompensation
is called, consists of two major conditions -
hyperglycaemia and ketoacidosis (See diagrams 1 and 2).
Hyperglycaemia produces an osmotic diuresis which may
bring about dehydration and hypovolaemia with peripheral
circulatory collapse. Due to its presence in the ECF,
the osmotically active glucose also causes intracellular
loss of water which leads to severe degrees of tissue
dehydration and electrolyte imbalance. In addition,
if/
if there is a marked insulin deficit, lipase
disinhibition and dimished intracellular glucose
utilisation will result in an overwhelming
mobilisation of fatty acids from adipose tissue
with the development of ketoacidosis (See
diagram 2).
These two conditions have great effects on
electrolyte balance, and it is important to
consider these defects - especially with regard
to sodium, potassium and phosphate.
Sodium balance - plasma sodium falls due to glucose
in the ECF producing an osmotic effect which moves
water out of the cellular compartment diluting
extracellular solutes; for every 100 mg/ 100 mis
increase in blood sugar there is a 1.6 mEq/1 fall
of plasma sodium (Katz 73). The total level of
sodium in the body is reduced by the loss of water
and sodium by the diuresing kidney. Hyponatraemia
as a clinical entity is manifested by cramps,
confusion, weakness and convulsions.
Potassium balance - total body potassium falls
because of the osmotic diuresis and because of the
increased levels of aldosterone brought about by
hypovolaemia and hyponatremia. Aldosterone promotes
retention of sodium at the distal tubule and excretion
of potassium. However, in acidosis due either to
ketosis or lactic acidosis in response to poor tissue
perfusion, plasma potassium may rise, as H+ ions are
exchanged for K"^ across the cell membrane. Insulin
deficiency also plays a part as this hormone has been
shown to promote the cellular uptake of potassium.
There may thus be a state of potassium depletion but
no demonstrable hypokalaemia, and this calls for
careful consideration of potassium balance while
correcting metabolic decompensation. Replacement
of potassium too oarly may cause hyperkalaemia,
whereas excessively vigerous treatment with insulin
and/or bicarbonate may precipitate a dangerous
hypokalaemia due to migration of K~^ ions into the
cells. Clinically, hyperkalaemia causes cardiac
arrhythmias; hypokalaemia decreases renal ability
to concentrate and may also precipitate cardiac
failure.
Phosphate balance - in hyperglycaemia there is
urinary loss of phosphate as glucose and phosphate
compete for tubular reabsorption (Pitts kk) - low
phosphate levels decrease cerebral function and may
cause/
cause weakness, tremors, haemolysis and poor
platelet function. In addition 2-3 DPGA levels
in red blood cells are reduced in uncontrolled
diabetes due both to phosphate depletion and to
a specific action of low pH (Alberti 72). This
causes an increased affinity of haemoglobin for
0-^(i.e. the 0^ dissociation curve is shifted
to the left). Acidosis, on the other hand, shifts
the curve to the right and in diabetic acidosis it
is thought that 2-3 DPGA is important in the
homeostasis of the red blood cells. However, if
the acidosis is corrected too rapidly, the low
2-3 DPGA levels cannot keep pace with the rising
pH in the face of phosphate depletion and this
results in decreased delivery of Oj. to the tissues
which may already be compromised by poor perfusion.
It has accordingly been suggested that fluid
regimens for the treatment of diabetic ketoacidosis
should include phosphate and exclude bicanbonate
(Alberti 72).
Although this sequence of events is the commonest
form of decompensation, there is another related
condition which arises in elderly patients with mild
late onset diabetes. This is termed hyperosmotic
non-ketotic diabetic coma (Libertino 70) and is
characterised by hyperglycaemia, hypernatremia,
dehydration and increased serum osmolality.
Ketoacidosis is absent although lactic acidosis is
common. The syndrome is precipitated or exacerbated
by surgery because of an endogenous or exogenous
glucose load which cannot be handled physiologically
at the cellular level. The endogenous load is
stress-related and dshe exogenousoload may result
from fluid therapy with dextrose without insulin.
Chronic renal insufficiency and congestive heart
disease are often present concomitantly and these
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The hypernatraemia may be explained by the fact that
in a precipitous osmotic diuresis HjO is lost to a
greater extent than Na"*", although why this should
cause hypernatraemia exclusively in this syndrome is
not clear; it is more likely that exogenous
administration of saline along with the dextrose is
a causative factor. Absence of ketosir is probably
due to the pancreas being able to secrete physiologically
active levels of insulin.
At this stage it is worth mentioning a condition which
is severely compromised by the presence of diabetes
mellitus - namely prostatic obstruction. After the
relief of urinary retention there is normally a post-
obstructive uropathy with profuse solute diuresis
(Moore 63). The solute load and the tubular disease,
both of which are caused by the chronic obstruction,
cause a severe diuresis due to the blockage of water
reabsorbtion. In diabetic hyperglycaemia, which may
be exacerbated by the surgical procedure, the soluble
diuresis is greatly increased. Sodium loss is
considerable, but much more water is lost as sodium
is reabsorbed by the tubule so that hypotonicity,
hjjpernatraemia and severe dehydration result.
Renal tubular acidosis also complicates the picture.
Energetic fluid management must therefore be applied
to counteract this until the tubules have recovered,
and careful diabetic management must be instituted
before the operation.
iii) Management of the diabetic surgical patient with regard
to potential metabolic decompensation.
It must be stressed that these metabolic changes are
due to diabetogenic surgical stress processes being
superimposed on the insulin-deficient diabetic state
and, in the normal patient, decompensation will not
readily occur. Accordingly, if the diabetic patient
is kept in a "normal" condition by judicious
administration of insulin and fluids, he should have
no more trouble from the immediate metabolic upset
of surgery than any other patient.
The problem is to maintain a balance between
hyperglycaemia and hypoglycaemia and, as we shall
see, this is achieved by witholding the endogenous
hypoglycaemic agent to a certain extent so that a
limited sugar infusion can be given during the
operation which prevents starvation ketoacidosis
but is small enough not to compromise the diabetic
exacerbation created by stress.
The specific approach can only be determined by taking
account/
account of the individual's diabetic status
and the severity of the surgical procedure. It
therefore behoves us to consider the surgical
management of the various manifestations of
diabetes under separate headings:
a) The Known Diabetic
1. late onset, diet-controlled
2. late onset, on oral hypoglycaemic
agents
3. insulin dependant.
b) The Undiagnosed Diabetic.
c) Emergency Surgery in Diabetes.
a) The Known Diabetic
If a patient requiring elective surgery is known to
be a diabetic, there are certain precautions which
can be taken regardless of the nature of his disease.
He should be admitted 1-2 days in advance for
evaluation of his condition; this must include
blood and urine glucose levels, OGTT, blood Na"*~,
K+, total COj_, ketoacids and urea. Haemocrit and
state of hydration should also be examined.
If there is any degree of decompensation due to poor
control or to some other factor such as an abcess,
this should be corrected by appropriate fluid and
insulin therapy. Cardiac and respiatory systems
should be carefully examined, as in all patients,
and the extent of any vascular disease ascertained.
Renal function should also receive careful scrutiny
especially if high urea levels are detected.
On the day of surgery, a fasting blood sugar is
obtained as a baseline, no breakfast is given and
a slow intravenous infusion of 1000 mis 5% dextrose
started to prevent starvation ketoacidosis. Post¬
operatively a second blood glucose must be taken to
check that the balance between hyperglycaemia and
hypoglycaemia has been maintained. On this basic
framework, the following refinements may be hung
according to the type of diabetes:
1. The Late onset diet-controlled Diabetic Patient.
The non-insulin dependant diabetic who is well
controlled by diet alone can usually get by on the
surveillance outlined above. If, however, the
diabetic state deteriorates in the post-operative
period, insulin may be temporarily required. A
single daily subcutaneous injection of 10 - 20
units of isophane (NPH) or lente insulin is
usually suitable (Steinke 71). The fear that &RCe
a patient takes insulin he must always take insulin
has not been substantiated; when the patient has
recovered/
recovered insulin can usually be discontinued,
especially if the surgery has removed the
reason for decompensation (eg. an abcess).
Although in general the single dose of insulin
is suitable, a sliding scale technique is
commonly used to try to obtain a more precise
control. This consists of the administration
of short acting soluble insulin according to
four hourly urine sugar levels. A typical
sequence would be - 15 units of soluble
insulin subcutaneously for a specimen,
10 units for a 34-specimen, 5 units for a
2 4-specimen and none for l+-or less. The amount
of insulin needs to be adjusted individually - that
is, it may be reduced for an elderly, cachetic
patient and increased for an obese patient.
The sliding scale technique certainly has its
advantages, as insulin requirements tend to
fluctuate after an operation. A major surgical
procedure may necessitate a sharp increase in
insulin dosage, but during convalescence insulin
requirements tend to returnrto pfe-operatjve levels
or even lower if a decompensating factor such as
an;.;abces6 or an inflamed gall bladder has been
removed, and thus hypoglycaemia may be precipitated
if insulin dosage is nbt tailored accordingly (Arky 71).
However, the disadvantage of estimating insulin
dosage on the basis of urine sugar are threefold.
First of all, it requires frequent urine collection.
Secondly, it assumes a normal renal threshold, but
with age the renal threshold often increases and, as
a result, the patient may be undertreated. Finally,
the insulin treatment is always several hours behind
the blood sugar, and thus the sliding scale technique
does not anticinate the need for insulin but rather
prescribes it retrospectively. It is therefore
probably better, if the sliding scale is to be
employed, to give a small prophylactic dose of NPH
insulin, supplemented if necessary by soluble insulin.
Whil%''discussing late onset, non-insulin dependant
diabetes, the phenomenon of hyperosmotic nori-ketotic
coma must not be omitted. The commonest cause of
this condition is the administration of large amounts
of glucose and saline to post-operative diabetics
with impaied renal function. It is important to note
that 5% dextrose and saline is the normal fluid
replacement in post-obstructive diuresis, and in
diabetes this therapy should be avoided. If coma
should develop, the following therapeutic regime
has/
has been suggested (Libertino 70). Soluble
insulin 50 units intravenously and 50 units
subcutaneously should be given and fluid
therapy carried out with 2 litres of -J normal
saline and 2.5% fructose given rapidly in a
drip. Fructose has the advantage of being
used intracellularly in the absence of insulin
and -J- normal saline soon replaces the sodium
and water lost in the glucose-induced diuresis.
Subsequent therapy consists of insulin every
2 hours until the blood glucose is less than
300 mg/100 mis, at which time 5% dextrose can
be started intravenously and the fructose-
saline discontinued. It is also noteworthy
that thrombotic phenomena have been suggested
as complicating hyperosmotic coma (Hobin 73)
and anticoagulant therapy may have a place.
However, this was an isolated report and the
association may have been co-incidental.
2. The Patient on Oral Hypoglycaemic Agents.
If the surgery is minor, the tablets should be
omitted pre-operatively and given before supper if short
acting (tolbutamide) or witheld until the next
day if of the long acting type (Chlorpropamide).
However, if the procedure is an extensive one, a
switch to insulin is usually made. This is
indicated of major surgery is planned, if general
anaesthetic is indicated, if intravenous feeding
is required for several days or if the diabetes
is poorly controlled. The insulin can be
administered on a sliding scale or as a small
subcutaneous injection of intermediate insulin
daily as before, and this should be continued
until oral intake is recommended. It has recently
been suggested that intravenous tolbutomide may be
more effective than insulin in these cases (Schmitt 68)
but an extensive comparison of the two methods is not
yet feasible.
3. The Diabetic Patient on Insulin.
Operations on an insulin dependant diabetic should
be scheduled early in the morning so that the period
of fasting is not prolonged. No subcutaneous
insulin should be given after the evening meal on
the night before and, of course, no foods or liquids
should be taken after midnight both to prevent
hyperglycaemia and for anaesthetic considerations.
Although/
Although most diabetics are maintained on intermediate
insulin which will have worn off by the day of surgery,
it must be ascertained that a long-acting variety has
not been given. On the day of operation, the total
insulin dosage should be reduced (usually byH, )
because of the limited glucose intake and the danger
of hypoglycaemia.
When minor surgery is to be performed, and if oral
intake can be resumed in the evening, insulin should
be witheld until the patient is in the recovery room
when V3 of the total dose is given. In this way
hypoglycaemia is avoided and hyperglycaemia is
unlikely because of previous fasting and the low stress
level of the operation.
In major surgery, however, when diabetogenic stress
processes are exaggerated, it is better to give ^3
of the total insulin dosage before the operation
and "3 after to be supplemented in the post-operative
period by soluble insulin on a sliding scale if
necessary. For example, if the normal dose of
insulin is 15 U soluble and 35 U NPH every morning,
then the patient should receive 5 U + 12 U
subcutaneously as a 5% dextrose infusion is started
pre-operatively. In the recovery room, another
5 U + 12 U should be given and his urine monitored
for sliding scale administration of soluble insulin
for the rest of the day. If on the next day intravenous
fluids are to be continued, insulin can again be
administered''3 in the morning and ^3 in the afternoon,
adjustments being made on the basis of fasting and
3 p.m. blood sugars. Once the patient has been
returned to oral feedings, insulin can be resumed
in a single injection. However, blood sugar
monitoring must be continued until it is certain
that the patient's insulin requirements have
stabilised.
It should be mentioned that some prefer to withold
all insulin on the day of surgery until the post¬
operative period when it is administered only by the
sliding scale technique so that hypoglycaemia is
avoided. However, the combination of the slow
glucose infusion and the metabolic effects of anxiety,
anaesthesia and surgery will counterbalance the
effects of the pre-operative insulin and, in practice,
hypoglycaemia is uncommon. If hypoglycaemia does
occur, it may well be that the patient has been on
an/
an unrestricted diet with large amounts of insulin, and
when a calorie controlled diet is administered in hospital
the insulin requirement is not adjusted.
Up to this point only the subcutaneous administration of
insulin has been advocated. However, some workers feel
that insulin should only be given intravenously both pre
and post operatively, until 100 gm of carbohydrates can
be taken orally, when subcutaneous administration can be
recommenced (Greene 67). They also suggest that only
soluble, short-acting insulin should be used around
operation. The rationale is that subcutaneous insulin,
even if soluble, has a more lingering effect than
intravenous and thus cannot be so readily controlled,
especially on the basis of urine sugars. However, I feel
that if the pre-operative medication is limited to soluble
intravenous insulin, the combination of dextrose infusion
and a long, stressful operation may precipitate hyper-
glycaemia and present difficulties ih the post-operative
fluid management.
It will be noticed that the verbs "feel" and "suggest" have
been prominent in the above discussion and this exemplifies
the subjective nature of diabetic management in the surgical
situation. To be quite honest, it is neither possible
nor particularly desirable to maintain rigid control of
diabetes during surgery and it must be remembered that
overtreatment in the pre or post operative period is more
. dangerous than mild occasional hyperglycaemia and glycosuria.
As long as an intelligent approach to diabetes is maintained,
the specific mode of treatment is of little account.
b) The Undiagnosed Diabetic Patient.
A mild diabetic may be so well compensated as to escape
detection, but under the stress of surgery develop hyper¬
glycaemia and ketoacidosis leading to dehydration and
electrolyte loss. Ideally, this should never happen
as all patients admitted for surgery should be screened
for diabetes. If hyperglycaemia or glycosuria are
detected, surgery should be postponed until the diabetic
state has been evaluated by an OGTT and perhapd a cortisone
OGTT. It must be remembered that the presence of sugar in
the urine does not always indicate diabetes mellitus.
Renal glycosuria, in which there is a low renal threshold
for glucose, does not require treatment but these patients
do have sugar in their urine and therefore easily develop
starvation ketosis when fasted. Thus they may exhibit
glycosuria and ketonuria and may be indistinguishable from
true diabetics if only urinary findings are taken into account.
c) Emergency Surgery in Diabetes.
If the patient is in a reasonable state of diabetic control,
emergency surgery may be carried out almost immediately. A
brief/
brief diabetic history, a urine test for sugar,
acetone and protein, a blood sugar determination,
a plasma acetone test and blood tests for bicarbonate,
electrolytes and urea determinations suffice for a
rapid diabetic evaluation.
On the other hand, if the diabetes is uncompensated,
either because it was unknown or because of underlying
disease such as a severe infection, it must be
controlled especially if acidosis is present and this
usually necessitates a delay of if - 5 hours. Of course,
in cases of uncontrolled haemorrhage, respiratory
insufficiency or raised intracranial pressure, which are
surgically correctable, operation should proceed
immediately and the patient treated for coma on the
table.
The treatment must be directed at three objectives -
rehydration, restoration of electrolyte balance and
restoration Pf acid-base balance. The amount and type
of fluid will vary with the patient's condition. If
there is severe dehydration with good cardiac and potential
renal function, 4 - 61 of normal saline are indicated.
If, however, cardiac or remal function is poor, a less
than normal saline infusion should be given; with severe
hyponatraemic non-ketotic coma, in an emergency it may
be best to omit sodium altogether and use 3% dextrose
despite the hyperglycaemia. Total body potassium will
probably be low as well, but it must be remembered that
because of the acidosis and insulin lack, plasma
potassium may be normal or even high. It is therefore
necessary to wait until potassium levels start to drop
before administering it in the infusion. If intra¬
venous bicarbonate is used for the rapid correction of
ketoacidosis and for lactic acidosis, it must be used
with extreme caution as a too rapid correction of
feicidOhiS precipitate a dangerous hypokalaemia. It
may also be justified to agd phosphate to the intravenous
fluid to compensate for the urinary loss which occurs in
the hyperglycaemia. Efficient therapy depends on
frequent blood sampling and estimation of blood glucose,
plasma (K*" ) and tot'al .po » and a foley catheter should
also be employed as restoration of urinary output dictates
the total amount of intravenous water required. The
amount of insulin required varies with the blood sugar,
timing of the last insulin injection and the magnitude of
the surgical procedure. None may be required until the
post-operative period or, if the blood sugar is raised
the usual daily dose may be given pre-operatively. If
the patient is ketoacidotic it is best to give 50 units
intravenously and 50 units subcutaneously to be repeated
every two hours if indicated by laboratory tests.
Before concluding this section on diabetes and emergency
surgery it is important to mention that diabetic
ketoacidosis may mimick an abdominal emergency such as
acute/
acute appendicitis (Steinke 70). Indeed this may he
the presentation of diabetes in childhood and give a picture
of abdominal pain and vomiting with an increase in blood
sugar and decreased bicarbonate. However, such a picture
may be due to, say, acute appendicitis with consequent
decompensation of previously undetected diabetes. It is
often impossible to come to a diagnosis at the outset and
the situation is best treated with insulin and fluids
before attempting laparotomy.






It is well documented that diabetics are particularly
susceptible to infection (Lipscomb 59> Thornton 71,
Koota 70, Younger 65) and this of course has important
implications in surgery. Wound infections have been
reported as being four times as common in diabetics
than in a normal population (Koota 70) and urinary tract
infection is a common ailment. How much of the latter
is due to depressed bactericidal activity in the diabetic
bladder mucosa and how much to prolonged catheterisation
is not clear (Lipscomb 59) but a careful watch must be
kept for bacturia, as pyelonephritis or even a fatal gram
negative septicaemia may develop. Staphylococcal, and
streptococcal skin infections are often seen in
diabetics (Thornton 71), especially in areas of vascular
insufficiency, and these may well give rise to a
bacteraemia or septicaemia.
Why do diabetics have a propensity for developing infections?
There are various proposed reasons, all of which may contribute
to the total explanation. Bacteria do not appear to grow
more quickly in diabetic blood (Cruickshank 54) and so the
rather simplistic view of hyperglycaemic blood as a good
culture medium is not generally accepted. Furthermore, it
has been demonstrated that gamma-globulin levels are
essentially normal, suggesting that a failure of the humoral
immune response is not a major factor (Lipscomb 59). It
must be mentioned, however, that a delay in the attainment of
maximal antibody titres was noted after injection of
staphylococcal toxin (Bates 41) and so B- lymphocytes May be
slightly compromised in diabetes. Certainly physiological
levels of insulin enhance lymphocyte-mediated cytotoxicity
(Strom 75) and hypoinsulinaemia may well be responsible for
suboptimal lymphocyte responsiveness.
Impairment of neutrophil function has also been observed in
patients with diabetes mellitus, although there is much debate
as to the aetiology. The early granulocyte phase of the local
c ellular/
cellular response was shown to be delayed in acidotic
patients only (Perillie 62) and in another study
phagocytic activity in neutrophils was depressed, again
uniquely in acidosis (Bybee 64). However, other work
has indicated that the antimicrobial action of neutrophils
was markedly reduced in non-ketotic patients and that the
defect was strongly related to hyperglycaemia (Bagdade 7k).
This study did not distinguish between phagocytosis and
intracellular killing, but both functions have been shown
to be depressed separately, using the lysostaphin
technique (Tan 71, Tan 72). To confuse matters further,
defective neutrophil function in diabetic patients has
also been noted independant of lkefcsacidosis and
hyperglycaemia (Tan 72). As several of the key enzymes
required for glucose metabolism in neutrophils are
insulin dependant (Klebhanoff 71) and as phagocytosis
depends on glucose metabolism, insulin deficiency could
well be implicated in the dysfunction.
Thus we have a rather equivocal picture; it is possible
that acidosis, hyperglycaemia and insulin deficiency
combine to render neutrophil function less than adequate
but, of course, there may be an even more basic
defect in the diabetic polymorph which is as yet
undetected.
Vascular insufficiency is also a major factor when
considering susceptibility to infection. Poor perfusion
due to atherosclerosis is common, especially in the distal
extremities, and this is almost certainly the most
important reason for the frequency of leg and foot lesions
in the diabetic. In addition, capillary clearance and
end-vessel reactivity to pressor substances are delayed in
diabetes mellitus (Mullane 70) and this may also compromise
resistance to infection.
What special precautions then must be taken with a view to
minimising the danger of infection in a diabetic patient
undergoing surgery? As in all patients, there must be a
scrupulous observation of aseptic technique,and many
surgeons avoid the use of diathermy, preferring to tie all
vessels in one hope of minimising any perfusion deficit
which may occur. Prompt drainage of any localised septic
process is vital, especially in areas of ischaemia where
systemic antibiotics are of little use and, in such cases,
topical antibacterial substances may be indicated (Moore 63).
When a septicaemia develops, this calls for aggressive
antibiotic treatment based, ideally, on blood culture
sensitivity studies, but therapy should be started
immediately and changed if necessary when the bacteriological
reports/
reports are returned. Prophylactic antibiotics
are also strongly indicated when a limb is to be
amputated. Recently,a group of workers have
applied local insulin to infected burns in
diabetes (Hoshi 73) bmt although the results
were promising no controlled study has yet been
done.
2. Wound healing
The tensile strength of healing abdominal wounds
has been shown to be reduced in rats rendered
diabetic with alloxan, especially when the diabetes
was poorly controlled (Rosenthai 62). This was
histologically related to decreased wound content
of collagen and delayed formation of granulation
tissue (Shah 74); at this point the well documented
neutrophil dysfunction should be remembered.
Although it is always dangerous to extrapolate
from animal models to human subjects, special care
should nevertheless be taken when suturing wounds
in diabetic patients, and removable sutures should
perhaps remain in place longer than usual. A
possible delay in fracture healing is another feature
noted in diabetics (Cozen 72) although this is not
well documented.
3. Myocardial Insufficiency
Any myocardial dysfunction must always be taken into
account when considering the management of the surgical
patient. Diabetics are particularly susceptible to
this, not only as a result of atherosclerosis but also
because of the high levels of FFA which are now thought
to depress myocardial function by raising Acetyl CoA
levels which in turn inhibits transfer of ATP from the








2. Surgery and Surgical Conditions Precipitating Diabetes
Mellitus and Related Metabolic Disorders.
Although the Important concept of surgery and trauma as
diabetogenic stimuli has been discussed, there are some
specific areas which require further scrutiny. These
may be classified as follows:
i) Pseudodiabetes
ii) Surgically related pancreatic damage
iii) Surgical conditions precipitating hypoglycaemia
iv) Surgical conditions associated with diabetes mellitus.
i) Pseudodiabetes
In any severe trauma, and especially in burns, the phenomenon
of pseudodiabetes may be seen. This is not to be confused
with the transient glycosuria without keto^iria which often
occurs in the first 48 hours, or exacerbation of pre-existant
diabetes mellitus, both of which are "normal" reactions to
stress. Pseudodiabetes is a rare condition, consisting of
gross glycosuria and hyperglycaemia without ketoacidosis which
is markedly insulin resistant (Muir 73). It tends to arise
several days post-trauma and lasts for several weeks; although
it diminishes spontaneously, dehydration, sodium and potassium
deficiency, and gross wasting due to excessive catabolism
occur (Stoner 73) and fatalities are not uncommon. The
aetiology is probably best thought of as a supranormal stress
reaction in which insulin antagonists, especially adrenaline,
remain at high levels for a long period of time after the
initial stimulus (Johnston 73). Treatment consists of high
calorie feeding in an attempt to spare the protein catabolism,
and insulin therapy to protect the islet cells (Muir 73).
ii) Surgically related pancreatic damage.
Direct trauma to the pancreas and carcinoma of that organ may
both cause enough damage to the islet cells to create an insulin
deficient diabetic state (Stoner 73). Indeed, diabetes mellitus
is sometimes a presenting symptom in pancreatic carcinoma
(Webster 75). However, the commonest cause of diabetes
related to pancreatic damage is total or subtotal pancreatectomy.
This is carried out not only in the treatment of carcinoma,
but also to alleviate the pain in chronic pancreatitis; when
contemplating such drastic measures in the latter condition,
however, it must be remembered that the alcoholic is particularly
prone to diabetic acidosis or insulin overdosage during periods
of inebriation.
A recently documented series of total pancreatectomies for
Walign^nt/
malignant tumours from 1%2-1973 has indicated that
76% of the patients were easily managed with
conventional insulin treatment whereas only 24%
developed brittle poorly controlled diabetes (Pliam 75).
This is perhaps not surprising as there can be no
residual insulin secreting capacity to complicate
matters. Another interesting finding from this study
is that diabetic neuropathy, nephropathy and retinopathy
were not major problems in the long term status of these
patients. In fact, only 7% developed retinopathy and
13% neuropathy and allthe long term complications only
occurred in the earlier section of the group. In
addition, the only patient with severe retinopathy was
a known diabetic for a long time before pancreatectomy.
This raises the question of whether the long term
complications of diabetes are related to insulin
deficiency and its sequelae at all, but are perhaps due
to some other basic defect. There is also the possibility
that, with the whole pancreas gone, the diabetes is more
easily and more effectively controlled due to the absence
of any indeterminate and perhaps fluctuating insulin
secreting capacity. It may seem far fetched, but would
juvenile diabetics benefit from total pancreatectomy?
The answer is that this series is too small and that not
enough patients have survived for a sufficient time to
carry out the extensive long term follow up which would be
required before significant conclusions could be drawn.
iii) Surgical conditions precipitating hypoglycaemia.
Hypophysectomy and adrenalectomy in the diabetic patient are
operations which require careful post-operative management.
As both operations tend to remove insulin antagonists -
ACTH and GH in the case of the pituitary, and Cortisol and
adrenaline with the adrenals - the patient is rendered
hypersensitive to insulin. As a result, insulin must be
administered cautiously and in very small doses. In this
context, it is worth noting that in acromegaly, diabetes
mellitus develops in about 25% of cases due to the
antagonistic effects of GH, and surgical hypophysectomy
is often the treatment of choice.
Another operation which gives rise to disorders of
carbohydrate metabolism, this time in the non-diabetic
patient as well, is partial or total gastrectomy. Due
to the loss of the "resevoir" function of the stomach,
immediate post prandial hyperglycaemia is frequently seen,
often accompanied by glycosuria, and without adequate
knowledge a diagnosis of diabetes mellitus might be
entertained. However, the hyperglycaemia has a
characteristic/
characteristic course which is best illustrated
by an OGTT
This is known as "lag storage". Note that although
the \ hour glucose is abnormally high, the 2 hour va^ue
is lower than usual, and the relative hypoglycaemia is
caused by the hyperinsulinaemia precipitated by the
transient hyperglycaemia. This hypoglycaemia may give
rise to some symptoms 2-3 hours after a meal, and has
been termed "delayed dumping". The treatment is similar
to the management of hypoglycaemia in early juvenile
diabetes and consists of the reduction of the amount of
simple sugars in the diet and replacement by slowly
absorbed starches and sugars in small frequent feedings
(Arky 71). Anticholinergic agents may also be useful
as rapid gastric emptying is an important aetiological
factor in the subtotal gastrectomy problem.
Pregnancy, although not strictly a surgical condition,
is also worth considering at this stage. A pregnant
diabetic woman requires large amounts of insulin due
to insulin resistance causedby placental hormonal factors
such as cortocosteroids and H.P.L. when the baby is
delivered, these factors disappear and insulin requirements
drop immediately to pre-pregnant levels. It is therefore
wise to reduce the dose of insulin by about a half on the
day of delivery, or to omit the usual insulin altogether
and work on the sliding scale principle. If, for some
reason, the normal dose of insulin has been given, the
mother should be covered by an intravenous infusion of
10% glucose; occasionally 50% "pushes" in the form of
intravenous injections may be required to prevent or treat
severe hypoglycaemia.
iv) Surgical conditions associated with diabetes.
There are some surgical conditions which are associated
with diabetes although their relationship with the
disease is not clear. Dupuytren's contracture is one
(Gunther 72), and another is carcinoma of the stomach
(Forgacs 73). Atrophic gastritis is frequent in diabetics
and/
and, indeed, auto-antibodies to gastric parietal cell
cytoplasm have been noted (Robertson 7k); this may
well predispose to carcinoma of the stomach and ties
up with the proposed autoimmune nature of juvenile
diabetes.
The incidence of diabetes in patients with cholelithiasis
was also found to be significantly higherthan in a normal
control population (Schmauss 70). It is significant to
note that in k0% of these patients who had had severe
pancreatitis 3-5 years previously, a diabetic disorder
was evident, a finding which may explain the association,
as pancreatitis is often implicated in both diabetes and
cholelithiasis.
Treatment of Diabetes Mellitus and its complications
by Surgery.
Finally we must consider the role which surgery has to play in
the treatment of the complications of diabetes and its potential
in the therapy of the actual disease itself. To facilitate







Quite apart from microangiopathy, which is thought to be related to
basement membrane deficiencies, diabetics are prone to atherosclerosis.
Aldose reductase is present in the aorta, and thus high glucose levels
produce a metabolic change within the wall, which may combine with
hyperlipidaemia to produce atherosclerosis in the large vessels(Clements
69).
This predisposition gives rise to vascular insufficiency, especially
in the lower extremities, which may call for surgical intervention.
Unfortunately, amputation is often the only course open to the surgeon
and, in general, the healing rate after an above-knee amputation is
greater than that for mid-leg. However, preservation of the knee
is of considerable benefit for the efficient use of a prosthesis,
and it is of great importance to amputate as low as possible but
without creating a wound which will not heal. Some authors consider
that the amputation level is best determined by skin temperature and
appearance alone, rather than relying on pulses and arteriography
(Echer 70). Different sources, however, hold the X-ray techniques
in gBeat esteem (Tolstedt 61) and it is thought that a below-knee
amputation is unlikely to heal if the superficial femoral artery
is found to be blocked at the adductor hiatus, or if the superior
geniculate artery is not patent.
The outlook is not always so bleak, however, and gangrene in the
foot of a diabetic may not have amputation as its inevitable outcome
if careful clinical evaluation is carried out (Williams 7k). Foot
gangrene develops not only because of a poor blood supply but also
because the patient is often unaware of minimal damage, owing to
his peripheral neuropathy. It must be impressed on patients with
neuropathy that careful foot hygene and early consultation are of
the essence, and if this is carried out the prognosis is
considerably better.
Foot lesions may be classified into three groups on the basis of
the clinical findings. Firstly, there is necrosis in the cold
foot. This is due to serious arterial insufficiency, necrosis
starting/
starting as distal gangrene which may become infected later.
In this case, major amputation is the inevitable result.
Secondly, necrosis in a hot foot indicates that the arterial
circulation is good and the condition usually develops as a
localized traumatic ulcer which becomes infected. Necrosis
results from the direct effect of bacterial toxins and the
consequent thrombosis in small vessels. Local excision and
preservation of part of the foot is possible in most cases, and
the wound should be left open to heal by granulation with skin
grafting later if necessary. The third presentation is necrosis
in a warm foot in which there is a proximal block of the arterial
system, with good collateral circulation. Gangrene starts with
an infection necrosis, but relative ischaemia hinders localisation.
Arterial surgery may be successful but this is more useful before
necrosis starts. Local excision should be attempted as healing
will octfur in 50% of cases (Williams 7k). Lumbar sympathectomy
has no place in the treatment of necrotic lesions of the foot,
but when the foot has healed it may be valuable in making it more
resistant to damage.
When major blood vessels have been blocked, usually by a
combination of atheromatous plaque and thrombus, arterial surgery
may have therapeutic effects if the distal vasculature is not
extensively involved. Thrombendarterectomy in which the thrombus
and intima are removed through an incision in the vessel wall is
often employed if the blockage is not extensive. However,
femoropopliteal saphenous bypass grafts are more effective when there
is a large occlusion at the femoral and popliteal arteries, and
when the blockage involves the aorta and iliac vessels, a Y-graft
of dacron or some similar material is often the best measure.
It must always be borne in mind that selection of patients is
important if useful results are to be achieved, and claudication
is a more hopeful presentation than necrosis or rest pain (Stipa 71).
ii) Renal Disease
Diabetic nephropathy is thought to be due to an enzyme-mediated
deposition of carbohydrate units in the basement membrane of
glomerular capilliaries which is active in insulin deficiency (Spiro 73).
However, even well-controlled juvenile diabetics often develop
glomerulonephritis and even have to be put on chronic dialysis for
which there is a high mortality and a tendency for neuropathy and
retinopathy to deteriorate (Leading Article 75). When the diabetes
is relatively uncomplicated interms of peripheral vascular disease,
severe blindness, or peripheral neuropathy, kidney transplantation
is often a more satisfactory treatment, especially if the donor is
a living relative. However, graft survival is less in diabetics
than in non-diabetics, and much poorer results are obtained when
cadaver kidneys are used. Urological complications are commoner
in diabetics after transplantation and a neurogenic bladder may be
a lethal complication because of intractable infection. Reversal
of the remaining complications doesnot usually occur after renal
transplantation although there is a suggestion that visual acuity
tends to stabilise; gastro-intestihal symptoms generally improve
suggesting/
suggesting that they are mostly uraemic in origin.
There is still no evidence that transplanted kidneys develop
diabetic abnormalities; basement membrane thickening does
occur in long-term survivors, but it is not known whether this
is a diabetic change or a consequence of transplantation.
Rejection phenomena are similar to those seen in non-diabetics,
although it should be noted that insulin requirements usually
rise following transplantation owing to the large doses of
steroids given for immunosuppresion (Beaudry 73). Taking
into consideration the fact that the diabetic with renal
insufficiency will deteriorate rapidly, and the finding
that retinopathy may advance more quickly as renal function
declines, it may be justifiable to consider transplantation
in diabetics at an earlier stage than normal, despite the
lower success rate of the operation,
iii) Retinopathy.
Diabetic retinopathy can be divided into two stages - "exudative"
or "Background" and "proliferative". The first type, which
occurs earlier in general, and is less severe, consists of
microanaurysms with associated dot haemorrhages, hard exudates,
and macular oedema. The more severe proliferative retinopathy
develops later and is characterised by neovascularisation,
preretinal haemorrhage and increased proliferation of connective
tissue. The pathogenesis of these conditions is not understood,
although basement membrane changes similar to those seen in
glomerular capillaries have been implicated. The surgical
treatment of retinopathy takes three forms - photocoagulation,
hypophysectomy and vitrectomy.
Photocoagulation can be directed against both background and
proliferative retinopathy, and is carried out using a xenon arc,
a ruby laser or an argon laser. Light energy from an xenon arc
is directed at the retina where it is absorbed forming a discrete
scar and areas of neovascularisation or bleeding are coagulated
and prevented from further extension (Baladimos 70). It is also
useful in the treatment of background retinopathy, where the
mechanism is probably related to the cauterisation of
capillaries (Multicentre Trial 75). The ruby and argon laser
are employed in a similar fashion, but they are also used to create
500 - 1000 scars throughout the retina, sparing the disc, macula
and maculopopular bundle. This, theoretically, alters the course
of proliferative retinopathy by occluding capillaries which supply
the new vessels, or by reducing the overall metabolic requirement
of the retina and hence the demand for vascular supply (Merin 71).
The argon laser (green light) is thought to be superior to the
ruby laser (red light) for destroying new vessels because of the
better absorption of green light by red haemaglobin. Two
controlled studies have been carried out on the use of the xenon
arc (Multicentre Trial 75) and the argon laser (Patz 73) for the
treatment/
treatment of macular oedema in background retinopathy.
In both cases the conclusion was that the treatment delays
the deterioration of diabetic maculopathy, but that the
difference between treated and untreated eyes did not
increase with longer follow-up. This suggests that
photocoagulation slows or stops the retinopathic process
for a time, but that it then proceeds at its old pace.
It was also noted that the prognosis was at its best in
those with a visual acuity of l^^or better (Multicentre
Trial 75) and accordingly photocoagulation should be
considered before retinal damage is too advanced. As
yet no controlled trials indicating the usefulness of
photocoagulation in proliferative retinopathy have been
carried out.
Hypophysectomy is another, more drastic, treatment for
retinopathy and is reserved for severe, progressive
proliferative disease with impending blindness when at
least one macula" is salvageable. Why this procedure
should have any effect is unknown, although it may be
related to the elimination of ACTH and GH, both of
which aggravate diabetes (q.v.). The techniques are
various, but the transsphenoidal approach with selective
microsurgical anterior pituitary ablation is becoming the
most popular. The results are generally quite good;
in 6k - 88%, stability or improvement of visual acuity
is achieved with clearing of vitreous opacities,
involution and disappearance of new vessels, resolution
of retinal oedema and a decrease in venous calibre
(Balodimos 71). However, the advantages of such a major
procedure have to be weighed against the considerable
disadvantages. For a start, in a proportion of patients
relapse occurs after a few years, and in all subjects
adrenal, thyroid and gonadal insufficiency necessitate
exogenous replacement therapy. Insulin requirements
generally fall by about 50% but insulin sensitivity
becomes extreme and the diabetes becomes brittle and hard
to control. Because this technique is reserved for
almost hopeless cases, its efficacy is hard to evaluate.
It is impossible, for example, to conduct a comparison of
the results with those of photocoagulation which is used
in the much earlier stages of retinopathy. However, if
hypophysectomy could be shown to bestow a significantly
better prognosis than ofcher techniques, it might be
justifiable to subject relatively young people to hormonal
mutilation in order that their eyesight might be preserved.
Vitrectomy, in which the whole vitreous is removed except
a relatively thin layer lying on the retina, is rarely
done in diabetes. Its main use is the removal of severe
vitreous haemorrhage which is unlikely to resorb, but
in diabetes, recurrent haemorrhage is the likely course
of/
of events (Stallard 68). Nevertheless, the operation
has recently been employed with a degree of success in
the elimination of pre-retinal traction bands which tend
to cause retinal detatchment and in the removal of
vascular proliferations (Machemer 75).
iv) Pancreatic Transplantation
At the present time the major, if not the basic defect
of diabetes mellitus appears to be insulin deficiency.
The value of surgery in the treatment of this factor is
extremely limited, but there are some procedures which
may prove useful in the overall management of juvenile
onset diabetes. Recently, bilateral solarectomy and
ligation at the middle and inferior suprarenal arteries
has been reported as being helpful in insulin resistant
diabetes (Chapo 7^), presumably by partially removing
the insulin-antagonistic effects of adrenaline and
Cortisol. However, this operation has not been widely
employed and is not well documented, so judgement must
accordingly be delayed. On the other hand, there is
an extensive literature relating to pancreatic
transplantation, a procedure which holds out a certain
amount of hope for the treatment of insulin dependant
diabetes where the pancreas is dysfunctional. As far
as attempts to use this technique on humans is concerned,
however, the procedure is still at a very early stage,
and most of the work described below has been done on
dogs.
Early efforts to obtain endocrine function with non¬
vascular implants of pancreatic tissue were disappointing
(Reemtsma 68) and so all recent attempts at total or
subtotal transplantation have included vascular
reconstruction. Thrombosis is a major complication
of the operation, partially due to the tortuosity of the
pancreatic vasculature, and partially because the exocrine
portion is highly sensitive to trauma and is prone to
release proteolytic enzymes. It is therefore necessary to
avoid diminished venous return from the grafted organ, and
this is best done by end to side venous anastomoses; arterial
inflow does not appear to be a complicating factor (Pennel 69).
Apart from the common factor of vascular anastomoses, the
techniques for transplantation are widely varied, but two major
methods can be described. Firstly, there is the pancreatico¬
duodenal graft, in which the donor's pancreas is transferred
along with its attatched duodenum (De Jode 66, Merkle 68,
Kelly 67, Idezuki 68, Largiader 67, Lillehei 70); the piece
of gut is then either included in the recipient's gastro¬
intestinal tract, or is exteriorised at one end and used as
a conduit for exocrine secretions. The major disadvantage
of this method is the severe effect of acute rejection on
the duodenal segment, when it displays extensive haemorrhage
and ulceration (Kelly 67, Merkel 68). Whether this is because
bowel is particularly antigenic, or whether it is merely the
gross structure of the organ which makes it highly susceptible
to the effects of rejection is not clear. The second type of
operation/
operation involves taking a sole pancreatic graft, partial
or total from a donor and reconstructing a vascular supply-
in the groin of the recipient using the iliac vessels
(Bergan 65, Tiexera 66 and 67, Kelly 67, Merkel 68,
Reemtsma 68, Gliedman 73). The advantages of this procedure
are easier technique and the avoidance of problems with
transplanted howel. However, drainage of the exocrine
pancreas presents some difficulties. Some workers believe
that failure to drain the exocrine secretions contributes to
the pancreatitis which always accompanies grafting, and
may sever&y compromise the survival of the organ. In
addition, when the duct is merely divided and tied, there is
a strong potential for continued exocrine leakage from the
gland, and in the immunosuppressed patieiit, the presence of
protein-rich fluid makes infection likely. Methods of
drainage have therefore been devised, including external
cutaneous fistulae (Reemtsma 68) and pancreatic duct-
wvureter anastomeses which appear t® /work satisfactorily.
On the other hand, some authors consider that duct ligation
is sufficient (Brynger 75, Tiexera 67); no controlled trial
has yet been done to determine which approach is the more
rational.
Grafting techniques always include a period of time when the
organ has no blood supply, and the pancreas is no exception.
Preservation between removal and implantation is usually
possible using low temperatures, and the pancreas has been
kept alive for up to 2k hours using both continuous
hypothermic albumin perfusion and simple hypothermia (Brynger 75).
When a pancreas is transplanted, restoration of endocrine
function is prompt; blood glucose is often normal within
2k hours (Sabiston 68) and both insulin and glucagon are
secreted by the graft (Brynger 75). In many cases, transient
hypoglycaemia is seen in the first post-operative day (Bergan 65,
Idezuki 68, Merkel 68, Reemtsma 68) associated with hyper-
insulinaemia (Lillehei 70), but the reason for this is not
understood. It was suggested that if pancreatic venous blood
was directed into the I.V.C, hormonal degredation would be
reduced owing to by-pass of the liver (Bergan 65). However,
a study involving orthotopic and heterotopic allografting
showed that there was no significant difference in glucose
metabolism between pancreatic venous return directed into
the systemic or portal systems (Idezuki 68). The most
likely explanation is transient, reversible ischaemia to the
islet cells suffered during the transfer. Hyperglycaemia
does not occub until rejection of the pancreas commences (Bergen 65)
and the glucose tolerance curve and insulin response to glucose
stimulation remain normal until this time (Lillehei 70).
Seemingly, then, carbohydrate metabolism is well controlled by
the/
the transplanted organ, but what of the long-term diabetic
complications? The literature is not extensive on this
aspect but in streptozotocin diabetic rats, pancreatic
transplantation was shown to halt the development of
nephropathy, although there was no evidence of reversal
of pre-existant lesions (Weil 7k) and a human study showed
that retinal haemorrhages and visual acuity problems
regressed after transplantation, although microangiopathic
retinopathy did not change in long-term survivors (Gliedman 73).
This indicates that although autoregulatory stabilisation of
carbohydrate metabolism may arrest or delay the development
of complications, actual disappearance of the lesions is
unlikely. However, some hope may be offered by the recently
reported regression of a Kimmalstiel-Wilson body in a diabetic
kidney grafted into a non-diabetic recipient (Barker 75),
but this unfortunately does not exclude the possibility that the
basic defect causing nephropathy remains after pancreatic
transplantation.
As in all allografting procedures, the most formidable problem
is rejection. In the early stages the pancreas becomes grossly
oedematous, indurated, and shows interstitial bleeding which in
the latter stages developes into a full-blown haemorrhagic
necrosis (Lillehei 70). Histologically, the process is
characterised by a mononuclear infiltrate which spares the islet
tissue until late on (Bergan 65), and even in the final stages
of chronic rejection, when the acinar tissue is almost
completely replaced by fibrous tissue, islet cells can still be
distinguished (Lillehei 70). This suggests that islet cells are less
antigenic than other tissue and certainly some work indicates that
the pancreas may be immunologically privileged. When kidney and
bowel are transplanted along with the pancreas, much greater
difficulties arise with rejection of the former two organs (Gliedman 73).
Indeed, in a series of 10 human patients where pancreas grafting
accompanied kidney transplantation, there had been no evidence of
pancreatic rejection although only two of the subjects were alive
at the time of publication (Lillehei 70). In addition, acinar
atrophy of the grafted pancreas in dogs, brought about by prior
duct ligation, improved the success rate of the operation by
k0% (Reemtsma 68).
One conclusion to be drawn from the above information is that the
pancreas as a whole is less antigenic than most tissues and that
the islet cells are even more privileged than the exocrine tissue.
However, using isolated pancreatic islets, it has recently been
shown that in rats, at least, the endocrine portion of the pancreas
is unequivocally as vulnerable to rejection as other tissues
(Reckard 73). How then do we explain the good results obtained
in experimental and clinical grafting? My contention is that the
pancreas is not immunologically privileged but that it may be less
susceptible to damage/by rejection because of its relatively
simple, homogenous structure when compared to the bowel or kidney.
It is also possible that the exocrine portion somehow protects the
endocrine cells from the invadin lymphocytes, and this is worth
bearing/
bearing in mind when cfinsidering the transplantation of
isolated islets.
If rejection of an organ is to be adequately and promptly
treated, some easily measurable indication of impending
gross dysfunction is necessary. Hyperglycaemia is the
obvious choice with the pancreas (Bergan 65)(Tiexera 66),
but it must be remembered that the use of steroids in
immunosuppression will have a hyperglycaemic effect itself,
and hence minor disturbances of carbohydrate mtfeabolism
cannot be adduced as evidence of rejection (Largiader 67).
Provocative tests, especially the intravenous OGTT, have
been successfully employed in predicting rejection before
the process has advanced (De Jode 66, Idezuki 68,
Largiader 67, Lillehei 70), and amylase levels have also
proved useful (Tiexera 67). It should be noted, however,
that the duct ligated pancreas gives rise to a permanent
hyperamylasaemia (Tiexera 67) and thus negates the
usefulness of the latter test. Rejection must be
distinguished from thrombosis, another major cause of
failure in the grafted pancreas, and this has been achieved
using arteriography (Lillehei 70).
Having considered detection of rejection, let us now turn
to its treatment. In most cases, standard therapy with
azathioprine and steroids is applied, and in humans this is
the same regime as is used for the renal transplantation
which is usually done concurrently. In dogs it was found
that heterologous antilymphocyte serum alone was a potent
immunosuppressive agent (Merkle 68) and this has been used
as an adjunct to the more convential treatment in human
subjects (Lillehei 70).
The concept of transplanting isolated islets was instituted
because it was thought initially that these cells might be
minimally antigenic, and the technique was made possible by
the development of a simple method of separating intact
islets from the pancreas (Lacy 67). As we have seen, the
immune privilege theory has been largely discredited, but
the method may still prove useful as it involves less trauma
and fewer gross complications than transplantation of the
pancreas itself. A major problem in this field is to find
the best site for depositing the transplanted cells.
Intraperitoneal islets certainly induce normoglycaemia in
streptozotocin-diabetic rats (Reckard 73), hut it has
recently been demonstrated that intra-portal administration
is superior as it minimises the required dosage and gives
a longer-term cure without recurrence (Reckard 7k). The
reason for this is not clear; portal insulin is no more
effedtive in lowering blood sugar than other routes, and
intraportal islets are no less immunogenic than
intraperitoneal- — immunosuppression must be used in both
cases/
cases to achieve prolonged results. It is possible that
better vascularisation of islets occurs in the liver than
in the peritoneal cavity. Human islet transplantation
has been carried out in one patient already immunosuppressed
for kidney grafting - the patient received 3 doges of islets
from 3 different donors, each dose being about 7% of the
normal pancreatic content, but although this decreased
insulin requirement, prolonged function was not obtained
(Barker 74). Owing to the low yield of the separation
technique, islet cell availability is a formidable problem,
but a new method for cultivating human islet cells has been
described (Lawson 74) and may provide part of the answer.
So the human experience with isolated islets is not
encouraging - but what of pancreatic transplantation in
general - is it a useful mode of therapy? A number of
attempts at human grafting have been carried out (Kelly 67,
Brynger 75, Lollehei 70, Gliedman 73> Johnston 68, Calne 75)
but most of these have been done in patients with terminal
renal disease, who were immunosuppressed anyway for kidney
transplants. In one study it was found that a staged
transplantation of pancreas with subsequent renal allografting
had a better prognosis than the synchronous operation (Gliedman 73).
It was suggested that poor renal function was due to an immunological
cross reaction with the pancreas, but the series was small and it
seems equally possible that the longer more extensive operation
may have compromised kidney function.
The results are not impressive, but they are encouraging, and
a recent survey gives the following:
Number of pancreatic transplants - 36
Number alive with functioning grafts - 1
Longest current survival with functioning graft - 2 years.
(Calne 75)
It must be remembered that these operations were not done under
ideal conditions and, even so, carbohydrate metabolism was
uniformly controlled in all patients until rejection set in, and
in most cases renal rejection was more severe than pancreatic.
In conclusion, it would seem that pancreatic transplantation
may offer the best hope for juvenile-onset diabetics as it
provides an autoregulatory system for insulin replacement, which
may control the development of long-term complications better than
discreet injections of the hormone. However, we must end on a
cautionary note. In a recent statement issued by the National
Institute of Arthritis, Metabolism and Digestive Disease and
endorsed by the American Diabetic Association, it was warned that
success in total or subtotal transplantation of the pancreas has
been "exceedingly limited" and should not be regarded as a form
of treatment of diabetes but as a highly experimental procedure
(Special Report 74). It should again be stressed that most
transplants are done on kidney recipients who are immunosuppressed
anyway; the long-term effectiveness of pancreatic transplantation
is/
is not yet substantiated and, at present, the inconvenience
of immunosuppression is greater than that of conventional
diabetic therapy. Another important consideration is
whether transplanted islet cell tissue will eventually
be affected by the disease; it must be remembered that in
experimental animals the diabetes is the result of mere
islet cell deficiency obtained by alloxan, strepto^ptcin
or surgical ablation, whereas the disease itself may well
have a systemic cellular or humoral defect as its basis.
Finally, the lesions which develop in these experimental
animals are assumed to be similar to human diabetic
complications and to have the same aetiology, but this
need not be so. Despite these objections, however, if
it transpires that pancreatic transplantation is effective
in controlling the sequelae of diabetes mellitus, then it
may be deemed justifiable to risk the rigours of
immonusuppression in an attempt to obtain successful
pancreatic grafting in the early stages of the disease.
Hopefully, improved methods of combating rejection and
more accurate histocompatability typing will reinforce
efforts in this direction.
Bibliography
1. Alberti K.et al. Lancet ii: 391-395 (1972)
2. Arky R. and Arons D. Med. Clin. N. Amer. 919-930 (1971)
3. Bagdade J. Diabetes 2^: 9-15 (197*0
4. Balodimos M. Med. Clin. N. Amer. 989-997 (1971)
5. Barker C. Diabetes 24 766-775 (1975)
6. Bates G. and Weiss C. Am. J. Dis. Child 62: 3^6-351 (1941)
7. Beaudry C. Canad. Med. Ass. J. 108: 887-890 (1973)
8. Bergan J. et al. Arch. Surg. £0: 521-526 (1965)
9. Brynger H. Acta. Chir. Scand. Suppl. i+53 (1975)
10. Bybee J. and Rogers D. J. Lab. Clin. Med. 64: 1-13 (196*0
11. Calne R. "Organ Grafts". Arnold (1975)
12. Chapo M. Pren. Med. Argent. 61: 879-891 (Abstract)(197*0
13. Clarke R. Brit. J. Anaesth. *+2: 45-53 (1970)
14. Clements R. et al. Science 166: 1007-1008 (1969)
15. Cozen L. Clin. Orthop. 82: 134-140 (1972)
16. Cruickshank A. J. Path. Bact. 67: 323-334 (1954)
17. De Jode L. and Howard J. Brit. J. Surg. 364-371 (1966)
18. De Leiris J. et al. Nature 2££: 746-747 (1975)
19. Ecker M. and Jacobs B. Diabetes 1^: 189-195 (1970)
20. Forgacs S. et al. Magy. Radial 25: 12-17 (1973)
21. Galloway J. and Shuman C. Int. Anaesth. Clin. |5: 437-466 (1967)
22. Gliedman M. et al. Surgery 74: 171-180 (1973)
23. Greene N. Int. Anaesth. Clin, jj; 427-436 (1967)
24. Gunther 0. and Miosga R. Z. Ges. Inn. Med. 27: 777-782 (1972)
25. Hobin F. and Maraist F. J. Fla. Med. Ass. 60: 25-26 (1973)
26. Hoshi M. et al. J. Jap. Diabet. Soc. 16: 203-207 (1973)
27. Idezuki Y. et al. Surg. Gynae. Obstet. 126: 1002-1014 (1968)
28/
28. Johnston I. Brit. J. Anaesth. 45; 252-255 (1973)
29. Katz M. New Eng. J. Med. 289: 843-844 (1973)
30. Kelly W. et al. Surgery 61: 827-837 (1967)
31. Klebhanoff S. Ann. Rev. Med. 22: 39-62 (1971)
32. Koota G. Mt. Sinai J. Med. ^7: 590-602 (1970)
33. Lacy P. and Kostianousky M. Diabetes l6: 35-39 (1967)
34. Largiader F. Surg. Clin. N. Amer. 47; 1363-1369 (1967)
35. Lawson R. and Pontala S. Surg. Forum 2^: 377-379 (1974)
36. Leading Article Brit. Med. J. iii: 397 (1975)
37. Leading Article Lancet ii: 637-638 (1972)
38. Libertino J. et al. J. Urol. 104: 642-645 (1970)
39. Lillehei J. et al. Ann. Surg. 172: 405-436 (1970)
40. Lipscomb H. et al. Southern Med. J. £2: 16-23 (1959)
41. Machemer R. Trans. Am. Acad. Ophthalmol Otolaryngol. 7.9: OP 394-395
(1975)
42. Marble A. and Steinke J. Anaesthesiol. 2ij-: 442-447 (1963)
43. Merkle F. et al. Surgery 6£: 291-297 (1968)
44. Merin S. and Yanko L. Harefuah 80: 241-242 (1971)
45. Moore F. "Metabolic Care of the Surgical Patient" W.B. Saunders and Co.
46. Muir I. and Barclay T. "Burns and their Treatment". Lloyd-Luke.
47. Mullane J. J. Surg. Res. 10: 101-103 (1970)
48. Multicentre Trial. Lancet ii: 1110-1113 (1975)
49. Patz A. et al. Trans. Am. Acad. Ophthalmal Otolaryngol. 77: OP 34-42
(1973)
50. Pennel T.C. et al. Amer. Surg. J5: 871-878 (1969)
51. Perillie P. et al. J. Lab. Clin. Med. 59: 1008-1015 (1962)
52. Pitts R. and Alexander R. Am. J. Physiol. 142: 648-662 (1944)
53. Pliam M. and Remine W. Arch. Surg. 110: 506-512 (1975)
54/
54. Reckard C. et al. Surgery 74: 91-99 (1973)
55. Reckard C. et al. Surg. Forum 25: 374-376 (1974)
56. Reemtsma K. et al. Ann. Surg. 168: 436-446 (1968)
57. Report of the NIAMDD Diabetes 2^: 987-988 (1974)
58. Robertson H. and Polk H. Surgery 75: 123-128 (1974)
59. Rosenthal S. et al. Surg. Gynaecol. Obstet. 115: 437-if/f2 (1962)
60. Rowe M. et al. Lancet i: 295-300 (1975)
61. Sabiston D. "Davis-Christopher Textbook of Surgery" (1968)
62. Schmauss A. et al. Munch. Med. Wschr. 112: 1297-1302 (1970)
63. Schmitt H. et al. Diabetologla 302-308 (1968)
64. Shah R. et al. J. Anim. Morphol. Physiol. 21: 124-131 (1974)
65. Shipp J. Int. Anaesth. Clin. 6: 189-209 (1968)
66. Spiro R. New Eng. J. Med. 288: 1337-1342 (1973)
67. Stallard H. "Eye Surgery" Williams and Williams (1968)
68. Steinke J. New Eng. J. Med. 282: 1472-1474 (1970)
69. Steinke J. Med. Clin. North Amer. 5£: 939-945 (1971)
70. Stipa S. and Wheelock F. Am. J. Surg. 121: 223-228 (1971)
71. Stoner H. and Heath D. Brit. J. Anaesth. 45: 244-251 (1973)
72. Strom T. Science 187: 1206 - 1208 (1975)
73. Tan J. et al. J. Lab. Clin. Med. $£ 78: 316-322 (1971)
74. Tan J. et al. J. Clin. Invest. 51: 96a (1972)
75. Tiexera E. et al. Surg. Forum 17: 205-207 (1966)
76. Tiexera E. and Bergab J. Arch. Surg. £5: 65-69 (1967)
77. Thorton M. Med. Clin. North Amer. 55: 931-938 (1971)
78. Tolstedt G. and Bell J. Arch. Surg. 8j>: 934-936 (1961)
79. Webster D. Brit. J. Surg. 62: 130-134 (1975)
80. Weil R. Surg. Forum 25: 386-388 (1974)
81. Williams H. et al. Arch. Surg. 108: 609-611 (1974)
82. Younger D. Med. Clin. North Amer. 4£: 1005-1013 (1965)
